Skip to content
10-Q

Quarterly Report

TRIMEDYNE INC

0001019687-15-000684

← back to feed
Filed
Feb 23, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2015 · Feb 20, 2015 18.4M sh
Long Term Debt Q1 2015 · Dec 31, 2014 $36K
Long Term Debt Q1 2015 · Sep 30, 2014 $43K
Short Term Investments Q1 2015 · Dec 31, 2014 $8K
Short Term Investments Q1 2015 · Sep 30, 2014 $8K
Stockholders Equity Q1 2015 · Dec 31, 2014 $3.44M
Stockholders Equity Q1 2015 · Sep 30, 2014 $3.61M
Current Liabilities Q1 2015 · Dec 31, 2014 $940K
Current Liabilities Q1 2015 · Sep 30, 2014 $1.05M
Total Liabilities Q1 2015 · Dec 31, 2014 $980K
Total Liabilities Q1 2015 · Sep 30, 2014 $1.1M
Current Assets Q1 2015 · Dec 31, 2014 $3.2M
Current Assets Q1 2015 · Sep 30, 2014 $3.46M
Total Assets Q1 2015 · Dec 31, 2014 $4.42M
Total Assets Q1 2015 · Sep 30, 2014 $4.71M
Shares Diluted Q1 2015 · Dec 31, 2013 18.4M sh
Capex Q1 2015 · Dec 31, 2013 $4K
Cash And Equivalents Q1 2015 · Dec 31, 2013 $1.6M
Cash And Equivalents Q1 2015 · Sep 30, 2013 $1.57M
Eps Diluted restated Q1 2015 · Dec 31, 2013 −$0.01
Eps Basic restated Q1 2015 · Dec 31, 2013 −$0.01
Sga Expense Q1 2015 · Dec 31, 2013 $549K
Rd Expense Q1 2015 · Dec 31, 2013 $124K
Net Income Q1 2015 · Dec 31, 2013 −$259K
Operating Income Q1 2015 · Dec 31, 2013 −$297K
Gross Profit Q1 2015 · Dec 31, 2013 $376K
Cost Of Revenue Q1 2015 · Dec 31, 2013 $1.02M
Revenue Q1 2015 · Dec 31, 2013 $191K